What are the genetic and environmental risk factors for chronic lymphoblastic leukemia (CLL)?
New CLL treatments, the standard of care and the importance of clonal evolution
TGR-1202 in CLL and non-Hodgkin lymphoma
Isavuconazole treatment for fungal disease in leukemia patients
Targeting ROR1 and a two-drug approach to cure CLL